Advanced Medical Solutions Group (LON:AMS) Shares Cross Below 200-Day Moving Average – Here’s What Happened

Advanced Medical Solutions Group plc (LON:AMS)’s share price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 218.61 ($2.84) and traded as low as GBX 188.80 ($2.45). Advanced Medical Solutions Group shares last traded at GBX 197 ($2.55), with a volume of 557,270 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank restated a “buy” rating and issued a GBX 300 ($3.89) price objective on shares of Advanced Medical Solutions Group in a research report on Wednesday, September 18th.

Advanced Medical Solutions Group Price Performance

The firm has a market capitalization of £512.77 million, a PE ratio of 4,780.00, a PEG ratio of 5.00 and a beta of 0.74. The stock has a 50-day moving average price of GBX 225.04 and a 200 day moving average price of GBX 219.32. The company has a quick ratio of 4.58, a current ratio of 8.39 and a debt-to-equity ratio of 37.01.

Advanced Medical Solutions Group Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, October 25th. Investors of record on Thursday, September 26th were given a dividend of GBX 0.77 ($0.01) per share. This represents a dividend yield of 0.32%. The ex-dividend date of this dividend was Thursday, September 26th. Advanced Medical Solutions Group’s payout ratio is 4,000.00%.

Insider Buying and Selling

In other news, insider Grahame Cook purchased 48,864 shares of the company’s stock in a transaction that occurred on Thursday, October 10th. The stock was purchased at an average cost of GBX 205 ($2.66) per share, for a total transaction of £100,171.20 ($129,906.89). 3.12% of the stock is owned by company insiders.

About Advanced Medical Solutions Group

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare.